Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Breast Cancer

Clinical Trial at: Compass Oncology - Vancouver

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-Tumor Activity of AC699 in Patients with Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer (AC699-001)

  • Details

ClinicalTrials.gov ID: NCT05654532
Diagnosis Type: Breast Cancer
USOR Number: 23009

  • Practice Details

210 SE 136th Ave
Vancouver, WA 98684
P: (360) 944-9889

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Compass Oncology - Vancouver

Harbinger Health Collection of Blood and Tissue Samples from Cancer andNon-Cancer Subjects for Validation of a Novel Blood-Based Multi-CancerScreening Test (HH-PRT-0001)

  • Details

ClinicalTrials.gov ID: NCT05435066
Diagnosis Type: Thyroid Cancer
USOR Number: 22311

  • Practice Details

210 SE 136th Ave
Vancouver, WA 98684
P: (360) 944-9889

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Compass Oncology - Tigard

Harbinger Health Collection of Blood and Tissue Samples from Cancer andNon-Cancer Subjects for Validation of a Novel Blood-Based Multi-CancerScreening Test (HH-PRT-0001)

  • Details

ClinicalTrials.gov ID: NCT05435066
Diagnosis Type: Thyroid Cancer
USOR Number: 22311

  • Practice Details

12123 SW 69th Avenue
Tigard, OR 97223
P: (971) 708-7600

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Compass Oncology - Portland

Harbinger Health Collection of Blood and Tissue Samples from Cancer andNon-Cancer Subjects for Validation of a Novel Blood-Based Multi-CancerScreening Test (HH-PRT-0001)

  • Details

ClinicalTrials.gov ID: NCT05435066
Diagnosis Type: Thyroid Cancer
USOR Number: 22311

  • Practice Details

265 North Broadway
Portland, OR 97227
P: (503) 280-1223

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Compass Oncology - Portland

Harbinger Health Collection of Blood and Tissue Samples from Cancer andNon-Cancer Subjects for Validation of a Novel Blood-Based Multi-CancerScreening Test (HH-PRT-0001)

  • Details

ClinicalTrials.gov ID: NCT05435066
Diagnosis Type: Thyroid Cancer
USOR Number: 22311

  • Practice Details

5050 NE Hoyt St, Suite 256
Portland, OR 97213
P: (503) 239-7767

More Details View Practice Page

Lung Cancer

Clinical Trial at: Compass Oncology - Portland

Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)

  • Details

ClinicalTrials.gov ID: NCT05885698
Diagnosis Type: Lung Cancer
USOR Number: 22285

  • Practice Details

5050 NE Hoyt St, Suite 256
Portland, OR 97213
P: (503) 239-7767

More Details View Practice Page

Lung Cancer

Clinical Trial at: Compass Oncology - Tigard

Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)

  • Details

ClinicalTrials.gov ID: NCT05885698
Diagnosis Type: Lung Cancer
USOR Number: 22285

  • Practice Details

12123 SW 69th Avenue
Tigard, OR 97223
P: (971) 708-7600

More Details View Practice Page

Lung Cancer

Clinical Trial at: Compass Oncology - Vancouver

Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)

  • Details

ClinicalTrials.gov ID: NCT05885698
Diagnosis Type: Lung Cancer
USOR Number: 22285

  • Practice Details

210 SE 136th Ave
Vancouver, WA 98684
P: (360) 944-9889

More Details View Practice Page

Lung Cancer

Clinical Trial at: Compass Oncology - Portland

Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)

  • Details

ClinicalTrials.gov ID: NCT05885698
Diagnosis Type: Lung Cancer
USOR Number: 22285

  • Practice Details

265 North Broadway
Portland, OR 97227
P: (503) 280-1223

More Details View Practice Page

Lung Cancer

Clinical Trial at: Compass Oncology - Tigard

A Phase 1/2 Dose Escalation/Expansion Study of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NGM707-IO-101)

  • Details

ClinicalTrials.gov ID: NCT04913337
Diagnosis Type: Lung Cancer
USOR Number: 22245

  • Practice Details

12123 SW 69th Avenue
Tigard, OR 97223
P: (971) 708-7600

More Details View Practice Page
1 2 3 … 13

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.